Recommended Pages at cookmedical.com
Cook Medical | Newsroom | January 18, 2011
cookmedical.com — “Bloomington, Ind., January 18, 2011 — Cook Medical has received premarket approval (PMA) from the U.S. Food and Drug Administration for its Formula™ Balloon-Expandable Renal Stent System. The approval includes both the Formula 414RX Balloon Expandable Renal Stent and the Formula 418 Balloon Expandable Renal Stent.” View full resource at cookmedical.com
Most Recently Shared on January 20, 2011 at 4:30 pm By:
Symposier Nephrology Health Business and Nephrology
Cook Medical Receives FDA Approval for Two Renal Stents. http://bit.ly/iiKk1F
Cook Medical | Newsroom | October 7, 2010
cookmedical.com — “Toronto, October 7, 2010 – Plastic surgeons treating patients faced with the difficult decision of reconstructive surgery after mastectomy now have access to breakthrough treatment options with Cook Medical’s Biodesign® Tissue Generation Matrix and Biodesign Nipple Reconstruction Cylinder. Designed to signal the body to encourage rapid tissue remodeling, the Biodesign grafts strike a critical balance of strength and flexibility that achieve aesthetically pleasing results. Introd” View full resource at cookmedical.com
Most Recently Shared on October 19, 2010 at 8:30 pm By:
@CookMedicalPR New Biologic Grafts Give #Plastic Surgeons Advanced Approach to #Breast #Reconstruction After #Mastectomyhttp://bit.ly/9Ga2K9
@CookMedicalPR #Cook Medical files PMA w/ FDA for #Zilver PTX Drug Eluting Stent to treat #PAD in the SFA: http://bit.ly/c9XO0W
cookmedical.com — “@CookMedicalPR #Cook Medical files PMA w/ FDA for #Zilver PTX Drug Eluting Stent to treat #PAD in the SFA: http://bit.ly/c9XO0W” View full resource at cookmedical.com
Most Recently Shared on June 30, 2010 at 7:20 pm By:
@CookMedicalPR #Cook Medical files PMA w/ FDA for #Zilver PTX Drug Eluting Stent to treat #PAD in the SFA: http://bit.ly/c9XO0W
Cook Medical | Newsroom | April 13, 2010
cookmedical.com — “April 13, 2010, Tokyo – Cook Medical, the world leader in endovascular repair of aortic aneurysms, today announces the availability of the Coda® balloon catheter (Coda) from Cook Medical to the Japanese endovascular market.(approval number 22200BZX00071000). Coda is an accessory used in endovascular aortic stenting procedures. The new balloon catheter is designed for both optimal expansion of Cook stent grafts and temporary occlusion of large blood vessels. Coda helps ” View full resource at cookmedical.com
Most Recently Shared on April 16, 2010 at 5:35 pm By:
@CookMedicalPR Cook Medical Launches New #EVAR Balloon In Japan: http://www.cookmedical.com/newsDetail.do?id=6211
Cook Medical | Newsroom | April 8, 2010
cookmedical.com — “Bloomington, Ind. – April 8, 2010 – Cook Medical's Women's Health division has released the Guardia™ AccessET Curved Embryo Transfer Catheter, featuring Cook's patented EchoTip® technology. The catheter's echogenic band allows the catheter tip to be seen more clearly under ultrasound, which can allow for more accurate embryo placement.” View full resource at cookmedical.com
Most Recently Shared on April 8, 2010 at 1:22 pm By:
@Cook#A.R.T. specialists Have A New Transfer Catheter 4 Improved Uterine Access & #Embryo Placement frm #Cook Med http://tinyurl.com/ydcjvte
Cook Medical | Newsroom | January 19, 2010
cookmedical.com — “Brisbane, Australia, December 21, 2009 — Australian-born medical breakthroughs and an increasing emphasis on minimally invasive surgery are proving healthy growth engines for local medical device manufacturer William A. Cook Australia at it starts its fourth decade in business here.” View full resource at cookmedical.com
Most Recently Shared on January 19, 2010 at 1:59 pm By:
RT @CookMedicalPR: Healthy Growth for #Aussie Medical Device Maker http://bit.ly/8kgvyR #hcsm
Cook Medical | Newsroom | January 19, 2010
cookmedical.com — “Miami, Fla., January 19, 2010 — Signaling its continued commitment to addressing the anatomy of the entire peripheral vasculature and combating disease with targeted diagnostic and interventional devices, Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy. In addition to live and simulated device demonstrations in booth #208, Cook's activities at the meeting include data presentations from two ongoing clinical trials ” View full resource at cookmedical.com
Most Recently Shared on January 19, 2010 at 1:59 pm By:
RT @CookMedicalPR: #Cook Medical Showcases Latest Advancements for Treating #Vascular Disease at ISET 2010 http://bit.ly/8L3U8G #hcsm
Cook Medical | Newsroom | October 20, 2009
cookmedical.com — “LAS VEGAS, Nev. - October 20, 2009 - In a tour de force of new product development and introduction, Cook Medical is introducing six new products in parallel to provide better treatment options to the physicians treating the 27 million people worldwide* afflicted with some form of peripheral arterial disease (PAD) and other diseases of the circulatory system.” View full resource at cookmedical.com
Most Recently Shared on October 20, 2009 at 2:50 pm By:
RT @CookMedicalPR: Cook Medical Unveils An Integrated Line of New Devices to Improve #PAD Patient Outcomes http://bit.ly/1MflSg
Cook Medical | Newsroom | September 30, 2009
cookmedical.com — “Bloomington, Ind., September 30, 2009 — Embryologists, fertility and reproductive specialists are invited to join a live, online chat event entitled, “In Vitro Maturation” at www.CookARTLab.com. The event will be held on Wednesday, October 7 at 7:00 pm Australian Eastern Time (AEST) and led by Professor Jeremy Thompson, a research scientist whose work is largely focused on early embryo development as the Head of the Early Development Group at the University of Adelaide, Austral” View full resource at cookmedical.com
Most Recently Shared on October 6, 2009 at 12:01 am By:
RT @CookMedicalPR: http://tinyurl.com/yelk4c8 IVF specialists around the world invited to first online chat to learn advances in IVM
Cook Medical | Newsroom | November 20, 2008
cookmedical.com — “New York, NY, November 20, 2008 – Cook Medical, the world leader in endovascular repair of aortic disease, has received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration (FDA) to begin a clinical trial for its Zenith Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft. The trial, which will include 24 sites, is designed to evaluate the safety and effectiveness of the smaller endograft delivery system in 120 patients, enabling ” View full resource at cookmedical.com
Most Recently Shared on May 12, 2009 at 11:38 am By:
This morning UNC's Dr. Mark Farber is performing first in U.S. implant of this device: http://bit.ly/t2R14
